Showing results (61-70 of 99) with videos related to
Sort By:
Pageof 10
Vaccines|November 10, 2019
Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-BElvira Couto, Vicenç Diaz-Brito, Beatriz Mothe, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 12, 2020
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell ResponsesBruna Oriol-Tordera, Alex Olvera, Clara Duran-Castells, et al.Nature Communications|May 13, 2024
Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomesJunqing Xie, Beatriz Mothe, Marta Alcalde Herraiz, et al.Plos Pathogens|August 8, 2020
Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV controlBruna Oriol-Tordera, Maria Berdasco, Anuska Llano, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2014
Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cellsEduardo Pauls, Alba Ruiz, Roger Badia, et al.Journal of Virology|July 15, 2011
High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV controlChristoph T Berger, Nicole Frahm, David A Price, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 25, 2025
Lessons from the European Mpox Outbreak: Strengthening Cohort Research for Future Pandemic PreparednessAlessandro Visentin, Alessandra Nazeri, José Luis Peñalvo, et al.The Journal of Clinical Investigation|November 29, 2024
Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoirIrene González-Navarro, Víctor Urrea, Cristina Gálvez, et al.Vaccines|December 11, 2019
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMixWesley de Jong, Lorna Leal, Jozefien Buyze, et al.European Journal of Immunology|October 16, 2015
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cellsNicola Ternette, Hongbing Yang, Thomas Partridge, et al.Pageof 10